Wells Fargo & Company Issues Positive Forecast for Cardinal Health (NYSE:CAH) Stock Price
Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...
Zacks.com on MSN8d
CAH Q2 Earnings and Sales Beat Estimates, 2025 EPS View Raised
Cardinal Health, Inc. CAH reported second-quarter fiscal 2025 adjusted earnings per share (EPS) of $1.93, which beat the ...
Cardinal Health (NYSE:CAH) Beats Q4 Sales Targets
Healthcare distributor and services company Cardinal Health (NYSE:CAH) beat Wall Street’s revenue expectations in Q4 CY2024, ...
Neurocrine Biosciences Q4 Earnings Preview: What To Expect After The New Drug Approval
Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...
Cardinal Health price target raised to $148 from $145 at Argus
Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.
Yahoo Finance28d
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
you should consider Cardinal Health (CAH). This company, which is in the Zacks Medical - Dental Supplies industry, shows potential for another earnings beat. This prescription drug distributor has ...